SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Zhiyong Yang, Jonathan V. Sweedler, Application of capillary electrophoresis for the early diagnosis of cancer, Analytical and Bioanalytical Chemistry, 2014, 406, 17, 4013

    CrossRef

  2. 2
    F. Cabrera-Mendoza, S. Gainza-Lagunes, I. Castañeda-Andrade, A. Castro-Zárate, Clinical relevance of the K-ras oncogene in colorectal cancer: Experience in a Mexican population, Revista de Gastroenterología de México (English Edition), 2014, 79, 3, 166

    CrossRef

  3. 3
    F. Cabrera-Mendoza, S. Gainza-Lagunes, I. Castañeda-Andrade, A. Castro-Zárate, Relevancia clínica del oncogén K-ras en cáncer de colon, experiencia en una población mexicana, Revista de Gastroenterología de México, 2014, 79, 3, 166

    CrossRef

  4. 4
    Gloria M. Slattum, Jody Rosenblatt, Tumour cell invasion: an emerging role for basal epithelial cell extrusion, Nature Reviews Cancer, 2014, 14, 7, 495

    CrossRef

  5. 5
    Ming-Chung Jiang, Chung-Min Yeh, Cheng-Jeng Tai, Hung-Chang Chen, Shu-Hui Lin, Tzu-Cheng Su, Shing-Chuan Shen, Woan-Ruoh Lee, Ching-Fong Liao, Li-Tzu Li, Ching-Hsiao Lee, Ying-Chun Chen, Kun-Tu Yeh, Chun-Chao Chang, CSE1L modulates Ras-induced cancer cell invasion: correlation of K-Ras mutation and CSE1L expression in colorectal cancer progression, The American Journal of Surgery, 2013, 206, 3, 418

    CrossRef

  6. 6
    C. Avgoustou, D. Giannousis, P. Penlidis, J. Gigondi, C. Boukis, A. Chatziioannou, Immunohistochemical analysis of K-RAS expression in curatively treated colorectal cancer patients: Correlations of clinicopathological features with clinical outcome, Hellenic Journal of Surgery, 2013, 85, 3, 165

    CrossRef

  7. 7
    Mark R. Wick, Oscar Nappi, John D. Pfeifer, Molecular techniques in anatomic pathology: An overview, Seminars in Diagnostic Pathology, 2013, 30, 4, 263

    CrossRef

  8. 8
    Jan-Willem Jachtenberg, Tom Bakker Schut, Pim French, Max Kros, Martine Lamfers, Sieger Leenstra, Raman spectroscopy can discriminate distinct glioma subtypes as defined by RNA expression profiling, Journal of Raman Spectroscopy, 2013, 44, 9
  9. 9
    Ksenija Brotto, Emina Malisic, Milena Cavic, Ana Krivokuca, Radmila Jankovic, The Usability of Allele-Specific PCR and Reverse-Hybridization Assays for KRAS Genotyping in Serbian Colorectal Cancer Patients, Digestive Diseases and Sciences, 2013, 58, 4, 998

    CrossRef

  10. 10
    S L Southern, T J Collard, B C Urban, V R Skeen, H J Smartt, A Hague, F Oakley, P A Townsend, N D Perkins, C Paraskeva, A C Williams, BAG-1 interacts with the p50–p50 homodimeric NF-κB complex: implications for colorectal carcinogenesis, Oncogene, 2012, 31, 22, 2761

    CrossRef

  11. 11
    Shun-ichi Suzuki, Mariko Komori, Mitsuharu Hirai, Norio Ureshino, Shinya Kimura, Development of a Novel, Fully-Automated Genotyping System: Principle and Applications, Sensors, 2012, 12, 12, 16614

    CrossRef

  12. 12
    Jayson Wang, James Hollingshead, Nabil El-Masry, Donna Horncastle, Ian Talbot, Ian Tomlinson, Malcolm R Alison, Mona El-Bahrawy, Expression of EGFR, HER2, Phosphorylated ERK and Phosphorylated MEK in Colonic Neoplasms of Familial Adenomatous Polyposis Patients, Journal of Gastrointestinal Cancer, 2012, 43, 3, 444

    CrossRef

  13. 13
    Avinash Gupta, Wasir Saka, David J Kerr, Personalized medicine in colorectal cancer: the evidence so far, Clinical Investigation, 2012, 2, 10, 1013

    CrossRef

  14. 14
    John M. Carethers, Proteomics, Genomics, and Molecular Biology in the Personalized Treatment of Colorectal Cancer, Journal of Gastrointestinal Surgery, 2012, 16, 9, 1648

    CrossRef

  15. 15
    Myung Hee Chang, In Kyu Lee, Yoon Si, Kyu Sang Lee, In-Sook Woo, Jae Ho Byun, Clinical impact of K-ras mutation in colorectal cancer patients treated with adjuvant FOLFOX, Cancer Chemotherapy and Pharmacology, 2011, 68, 2, 317

    CrossRef

  16. 16
    Na Xu, Si Qi Wang, Dan Tan, Yawei Gao, Guonan Lin, Rongwen Xi, EGFR, Wingless and JAK/STAT signaling cooperatively maintain Drosophila intestinal stem cells, Developmental Biology, 2011, 354, 1, 31

    CrossRef

  17. 17
    Satu Oltedal, Ole Gunnar Aasprong, Jannicke H. Møller, Hartwig Kørner, Bjørnar Gilje, Kjersti Tjensvoll, Elke M. Birkemeyer, Reino Heikkilä, Rune Smaaland, Oddmund Nordgård, Heterogeneous distribution of K-ras mutations in primary colon carcinomas: implications for EGFR-directed therapy, International Journal of Colorectal Disease, 2011, 26, 10, 1271

    CrossRef

  18. 18
    Huidan Zhang, Xiaonan Wang, Qian Ma, Zhe Zhou, Jin Fang, Rapid detection of low-abundance K-ras mutation in stools of colorectal cancer patients using chip-based temperature gradient capillary electrophoresis, Laboratory Investigation, 2011, 91, 5, 788

    CrossRef

  19. 19
    Shouji Shimoyama, Statins are logical candidates for overcoming limitations of targeting therapies on malignancy: their potential application to gastrointestinal cancers, Cancer Chemotherapy and Pharmacology, 2011, 67, 4, 729

    CrossRef

  20. 20
    Dennis J Ahnen, The American College of Gastroenterology Emily Couric Lecture—The Adenoma–Carcinoma Sequence Revisited: Has the Era of Genetic Tailoring Finally Arrived?, The American Journal of Gastroenterology, 2011, 106, 2, 190

    CrossRef

  21. 21
    Peiju Qiu, Huashi Guan, Ping Dong, Shanshan Guo, Jinkai Zheng, Shiming Li, Yun Chen, Chi-Tang Ho, Min-Hsiung Pan, David Julian McClements, Hang Xiao, The inhibitory effects of 5-hydroxy-3,6,7,8,3′,4′-hexamethoxyflavone on human colon cancer cells, Molecular Nutrition & Food Research, 2011, 55, 10
  22. 22
    Fernando Vidal-Vanaclocha, The Liver Prometastatic Reaction of Cancer Patients: Implications for Microenvironment-Dependent Colon Cancer Gene Regulation, Cancer Microenvironment, 2011, 4, 2, 163

    CrossRef

  23. 23
    Sanjay Harrison, Harrison Benziger, The molecular biology of colorectal carcinoma and its implications: A review, The Surgeon, 2011, 9, 4, 200

    CrossRef

  24. You have free access to this content24
    Brenda K. Edwards, Elizabeth Ward, Betsy A. Kohler, Christie Eheman, Ann G. Zauber, Robert N. Anderson, Ahmedin Jemal, Maria J. Schymura, Iris Lansdorp-Vogelaar, Laura C. Seeff, Marjolein van Ballegooijen, S. Luuk Goede, Lynn A. G. Ries, Annual report to the nation on the status of cancer, 1975-2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates, Cancer, 2010, 116, 3
  25. 25
    Takeru Shiroiwa, Yoshiharu Motoo, Kiichiro Tsutani, Cost-Effectiveness Analysis of KRAS Testing and Cetuximab as Last-Line Therapy for Colorectal Cancer, Molecular Diagnosis & Therapy, 2010, 14, 6, 375

    CrossRef

  26. 26
    Maria Rosaria De Miglio, Antonica Mura, Maria Gabriela Uras, Alessandra Manca, Marcella Contini, Luciano Murgia, Angelo Zinellu, Salvatore Sotgia, Ciriaco Carru, Giovannino Massarelli, Paolo Cossu-Rocca, High Sensitivity of Reverse-hybridization Methodology in the Detection of KRAS Mutations from Formalin-fixed Paraffin-embedded Colorectal Cancer Samples, Diagnostic Molecular Pathology, 2010, 19, 4, 201

    CrossRef

  27. 27
    R. Knüchel-Clarke, H.H. Lutz, J. Floege, N. Marx, T.H. Brümmendorf, C. Trautwein, Wenn nur noch der Pathologe hilft, Der Internist, 2010, 51, 4, 463

    CrossRef

  28. 28
    László Kopper, József Tímár, A KRAS mutációjának hazai körvizsgálata („validálási” vizsgálat) vastagbélrákban, Magyar Onkológia, 2009, 53, 4, 361

    CrossRef

  29. 29
    Barbara L Parsons, Fanxue Meng, K-RASmutation in the screening, prognosis and treatment of cancer, Biomarkers in Medicine, 2009, 3, 6, 757

    CrossRef

  30. 30
    Ranit Kedmi, Dan Peer, RNAi nanoparticles in the service of personalized medicine, Nanomedicine, 2009, 4, 8, 853

    CrossRef